Lung Physiological Variations in COVID-19 Patients and Inhalation Therapy Development for Remodeled Lungs
In response to the unmet need for effective treatments for symptomatic patients, research efforts of inhaled therapy for COVID-19 patients have been pursued since the pandemic began. However, inhalation drug delivery to the lungs is sensitive to the lung anatomy and physiology, which can be signific...
Main Authors: | Jinxiang Xi, Brendan Walfield, Xiuhua April Si, Alexander A. Bankier |
---|---|
Format: | Article |
Language: | English |
Published: |
Ital Publication
2021-09-01
|
Series: | SciMedicine Journal |
Subjects: | |
Online Access: | https://www.scimedjournal.org/index.php/SMJ/article/view/372 |
Similar Items
-
Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD
by: Soltani A, et al.
Published: (2016-09-01) -
Effects of the Addition of Beta2-agonist Tulobuterol Patches to Inhaled Corticosteroid in Patients with Asthma
by: Soichiro Hozawa, et al.
Published: (2009-01-01) -
Reduction of Eosinophils in Small Airways by Inhaled Steroids is Insufficient in Patients with Adult Asthma
by: Hiroshi Tanaka, et al.
Published: (2006-01-01) -
INHALATION THERAPY IN CHILDREN: ISSUES AND OPTIONS
by: L. R. Selimzyanova, et al.
Published: (2014-03-01) -
Inhalation therapy for bronchial asthma in the conditions of paediatric section
by: W. V. Delyagin
Published: (2020-07-01)